formoterol fumarate

FDA Drug Profile — formoterol fumarate, Formoterol Fumarate

formoterol fumarate is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand names including formoterol fumarate, Formoterol Fumarate. Available dosage forms: powder, solution.

Drug Details

Generic Name
formoterol fumarate
Brand Names
formoterol fumarate, Formoterol Fumarate
Application Number
ANDA215053
Sponsor
Fermion Oy
NDC Codes
3
Dosage Forms
POWDER, SOLUTION
Routes
RESPIRATORY (INHALATION)
Active Ingredients
FORMOTEROL FUMARATE

Indications and Usage

1 INDICATIONS AND USAGE BREZTRI AEROSPHERE is a combination of budesonide, an inhaled corticosteroid (ICS); glycopyrrolate, an anticholinergic; and formoterol fumarate, a long-acting beta 2 -adrenergic agonist (LABA), indicated for: • the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. ( 1.1 ) • the maintenance treatment of asthma in adult and pediatric patients 12 years of age and older. ( 1.2 ) Limitations of Use: Not indicated for the relief of acute bronchospasm. ( 1.3 , 5.1 , 5.2 ) 1.1 Maintenance Treatment of Chronic Obstructive Pulmonary Disease BREZTRI AEROSPHERE is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. 1.2 Maintenance Treatment of Asthma BREZTRI AEROSPHERE is indicated for the maintenance treatment of asthma in adult and pediatric patients 12 years of age and older. 1.3 Limitations of Use BREZTRI AEROSPHERE is not indicated for the relief of acute bronchospasm [see Warnings and Precautions (5.1 , 5.2) ] .